The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.
Open accessAbstract
Homeostasis of multicellular organisms is critically dependent on the correct interpretation of the plethora of signals which cells are exposed to during their lifespan. Various soluble factors regulate the activation state of cellular receptors which are coupled to a complex signal transduction network that ultimately generates signals defining the required biological response. The epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases represents both key regulators of normal cellular development as well as critical players in a variety of pathophysiological phenomena. The aim of this review is to give a broad overview of signal transduction networks that are controlled by the EGFR superfamily of receptors in health and disease and its application for target-selective therapeutic intervention. Since the EGFR and HER2 were recently identified as critical players in the transduction of signals by a variety of cell surface receptors, such as G-protein-coupled receptors and integrins, our special focus is the mechanisms and significance of the interconnectivity between heterologous signalling systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–231 of 231
The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding
Barbacci-Tobin, E. G., Guarino, B. C., Stroh, J. G., Singleton, D. H., Rosnack, K. J., Moyer, J. D., & Andrews, G. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.16.9585 · Cited by 95
Dempsey, P. J., Meise, K. S., Yoshitake, Y., Nishikawa, K., & Coffey, R. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.747 · Cited by 92
Altered gene expression in drug-resistant human breast cancer cells.
Wosikowski, K., Schuurhuis, D. H., Kops, G. J. P. L., Saceda, M., & Bates, S. E. (1997) · PubMed · Cited by 90
Tyrosine Phosphorylation and Proteolysis
Vecchi, M., Rudolph‐Owen, L. A., Brown, C. L., Dempsey, P. J., & Carpenter, G. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20589 · Cited by 89
Bagowski, C. P., Stein‐Gerlach, M., Choidas, A., & Ullrich, A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.20.5567 · Cited by 87
Self-citationSeth, D., Shaw, K., Jazayeri, J. A., & Leedman, P. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690407 · Cited by 86
Crovello, C. S., Lai, C., Cantley, L. C., & Carraway, K. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26954 · Cited by 85
EGF Receptor Transactivation Mediated by the Proteolytic Production of EGF-like Agonists
Carpenter, G. F. (2000) · Science s STKE · doi:10.1126/stke.2000.15.pe1 · Cited by 84
Tassi, E., Biesova, Z., Fiore, P. P. D., Gutkind, J. S., & Wong, W. T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33287 · Cited by 83
Laffargue, M., Raynal, P., Yart, A., Peres, C., Wetzker, R., Roche, S., Payrastre, B., & Chap, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32835 · Cited by 80
Slack, B. E. (2000) · Biochemical Journal · doi:10.1042/bj3480381 · Cited by 78
Uckun, F. M., Narla, R. K., Zeren, T., Yanishevski, Y., Myers, D. E., Waurzyniak, B. J., Ek, R. O., Schneider, E., Messinger, Y. H., Chelstrom, L. M., et al. (1998) · PubMed · Cited by 78
Dong, J., & Wiley, H. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.557 · Cited by 74
Damstrup, L., Kuwada, S. K., Dempsey, P. J., Brown, C. L., Hawkey, C. J., Poulsen, H. S., Wiley, H. S., & Coffey, R. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690456 · Cited by 70
Activated release of membrane-anchored TGF-alpha in the absence of cytosol
Bosenberg, M., Pandiella, A., & Massagué, J. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.1.95 · Cited by 70
Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
Uckun, F. M., Narla, R. K., Jun, X., Zeren, T., Venkatachalam, T. K., Waddick, K. G., Rostostev, A., & Myers, D. E. (1998) · PubMed · Cited by 69
Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K., Bigner, D. D., & Pastan, I. (1995) · PubMed · Cited by 69
Grosse, R., Roelle, S., Herrlich, A., Höhn, J., & Gudermann, T. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12251 · Cited by 68
Murasawa, S., Matsubara, H., Mori, Y., Masaki, H., Tsutsumi, Y., Shibasaki, Y., Kitabayashi, I., Tanaka, Y., Fujiyama, S., Koyama, Y., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909999199 · Cited by 67
Hsieh, E., Shepherd, F. A., & Tsao, M. (2000) · Lung Cancer · doi:10.1016/s0169-5002(00)00116-1 · Cited by 66
Hills, D., Rowlinson‐Busza, G., & Gullick, W. J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630414 · Cited by 64
Thorne, B. A., & Plowman, G. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1635-1646.1994 · Cited by 60
Release of the Neuregulin Functional Polypeptide Requires Its Cytoplasmic Tail
Liu, X., Hwang, H., Cao, L., Wen, D., Liu, N., Graham, R. M., & Zhou, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34335 · Cited by 60
Fan, P., & Goff, S. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7591-7601.2000 · Cited by 60
Shao, Z. M., Wu, J., Shen, Z. Z., & Barsky, S. H. (1998) · PubMed · Cited by 55
Mannon, P., & Mele, J. M. (2000) · Biochemical Journal · doi:10.1042/bj3500655 · Cited by 53
Vaingankar, S. M., & Martins‐Green, M. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5226 · Cited by 41
Cr, K., Borrello, I., Porter, L., Comoglio, P. M., & Schlessinger, J. (1989) · PubMed · Cited by 41
Preclinical and Clinical Pharmacology of Antisense Oligonucleotides
Marcusson, E. G., Yacyshyn, B., Shanahan, W. R., & Dean, N. M. (1999) · Molecular Biotechnology · doi:10.1385/mb:12:1:1 · Cited by 32
Caruso, M. L., & Valentini, A. M. (1997) · PubMed · Cited by 27
HER2/neu: A Target for Breast Cancer Therapy
Zwick, E., Wallasch, C., & Ullrich, A. (2000) · Breast Disease · doi:10.3233/bd-1999-11102 · Cited by 11
Self-citation
Cited by
Moasser, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210477 · Cited by 1,219
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
Witton, C. J., Reeves, J. R., Going, J. J., Cooke, T. G., & Bartlett, J. M. (2003) · The Journal of Pathology · doi:10.1002/path.1370 · Cited by 590
Xiong, H. Q., Rosenberg, A., LoBuglio, A., Schmidt, W., Wolff, R. A., Deutsch, J., Needle, M., & Abbruzzese, J. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.040 · Cited by 479
Targeting the ERBB family in cancer: couples therapy
Tebbutt, N., Pedersen, M. W., & Johns, T. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3559 · Cited by 466
Metadata
- Authors
- Prenzel, N., Fischer, O. M., Streit, S., Hart, S., & Ullrich, A.
- Venue
- Endocrine-related cancer
- Publisher
- Bioscientifica
- Published
- 2001-03
- Volume
- 8
- Issue
- 1
- Pages
- 11-31
- ISSN
- 1351-0088 (ISSN-L)
- OpenAlex
- W2134850272
- Cited by
- 673
- References
- 231
- FWCI
- 19.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.